Elevar Therapeutics and Hengrui Pharma have resubmitted applications to the FDA seeking approval of rivoceranib plus ...
AIDS Healthcare Foundation settles for $1.44 million over Medicare Advantage false claims, highlighting ongoing federal focus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results